The Cancer Convergence is a research journal that publishes research in the field of oncology, cancer initiation, tumour progression, cancer treatment strategies. This journal is published by the BMC. The ISSN of this journal is .
Also, please check the following important details about cancer convergence: Publisher, ISSN, Ranking, Indexing, Impact Factor (if applicable), Publication fee (APC), Review Time, and Acceptance Rate.
According to Clarivate's JCR, journals indexed in SCIE/SSCI have an impact factor.
The ISSN (International Standard Serial Number) is an 8-digit code used to uniquely identify journals. ISSN numbers are assigned by a network of ISSN National Centres, usually located at national libraries and coordinated by the ISSN International Centre based in Paris. The International Centre is an intergovernmental organization created in 1974 through an agreement between UNESCO and the French government.
Journal Title: | Cancer Convergence |
Publisher: | BMC |
P-ISSN: | |
E-ISSN: | 2366-6196 |
Language: | English |
Country of Publisher: | United Kingdom |
APC: | Yes |
Processing Time (Weeks): | 36 |
Review Process: | Anonymous peer review |
Subjects: | Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens |
The cancer convergence is indexed in:
An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.
The Web of Science Core Collection includes the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (AHCI), and Emerging Sources Citation Index (ESCI).
According to journal website, the publication fee of cancer convergence is around 1140 EUR; 1340 USD; 1040 GBP.
The cancer convergence has also Journal waiver policy (for developing countries, authors etc).
An article processing charge (APC), also known as a publication fee, is a fee which is sometimes charged to authors. Most commonly, it is involved in making a work available as open access (OA), in either a full OA journal or in a hybrid journal.
The Journal Publication Time means the average number of weeks between article submission and publication. According to the journal website, the cancer convergence publishes research articles in 36 weeks on an average.
Visit to the official website of the journal/ conference to check the details about call for papers.
If your research is related to oncology, cancer initiation, tumour progression, cancer treatment strategies, then visit the official website of cancer convergence and send your manuscript.
SIMILIAR JOURNALS
ADVANCES IN CANCER BIOLOGY-METASTASIS
ISSN:ADVANCES IN RADIATION ONCOLOGY
ISSN:BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY
ISSN: 1179-9889BREAST CANCER-BASIC AND CLINICAL RESEARCH
ISSN: 1178-2234CANCER RESEARCH COMMUNICATIONS
ISSN:TOP RESEARCH JOURNALS